186 related articles for article (PubMed ID: 31707225)
1. Doxorubicin-doxorubicin conjugate prodrug as drug self-delivery system for intracellular pH-triggered slow release.
Li J; Li X; Liu P
Colloids Surf B Biointerfaces; 2020 Jan; 185():110608. PubMed ID: 31707225
[TBL] [Abstract][Full Text] [Related]
2. Rod-like cellulose nanocrystal/cis-aconityl-doxorubicin prodrug: A fluorescence-visible drug delivery system with enhanced cellular uptake and intracellular drug controlled release.
Li N; Lu W; Yu J; Xiao Y; Liu S; Gan L; Huang J
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():179-189. PubMed ID: 30033244
[TBL] [Abstract][Full Text] [Related]
3. pH/Reduction Dual-Triggered Degradable Poly(doxorubicin) Prodrug Nanoparticles for Leakage-Free Tumor-Specific Self-Delivery.
Li J; Liu P
Macromol Rapid Commun; 2018 Sep; 39(18):e1800381. PubMed ID: 30073742
[TBL] [Abstract][Full Text] [Related]
4.
Dong Y; Du P; Liu P
Int J Pharm; 2020 Oct; 588():119723. PubMed ID: 32755688
[TBL] [Abstract][Full Text] [Related]
5. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
Xu M; Qian J; Liu X; Liu T; Wang H
Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
[TBL] [Abstract][Full Text] [Related]
6. Coordinated pH/redox dual-sensitive and hepatoma-targeted multifunctional polymeric micelle system for stimuli-triggered doxorubicin release: Synthesis, characterization and in vitro evaluation.
Wang L; Tian B; Zhang J; Li K; Liang Y; Sun Y; Ding Y; Han J
Int J Pharm; 2016 Mar; 501(1-2):221-35. PubMed ID: 26851356
[TBL] [Abstract][Full Text] [Related]
7. Photo- and pH- Dual-Responsive β-Cyclodextrin-Based Supramolecular Prodrug Complex Self-Assemblies for Programmed Drug Delivery.
Bai Y; Liu CP; Song X; Zhuo L; Bu H; Tian W
Chem Asian J; 2018 Dec; 13(24):3903-3911. PubMed ID: 30311448
[TBL] [Abstract][Full Text] [Related]
8. Polymeric prodrug microspheres with tumor intracellular microenvironment bioreducible degradation, pH-triggered "off-on" fluorescence and drug release for precise imaging-guided diagnosis and chemotherapy.
Pei M; Li G; Ma K; Li J; Wang Y; Liu P
Colloids Surf B Biointerfaces; 2019 May; 177():313-320. PubMed ID: 30771583
[TBL] [Abstract][Full Text] [Related]
9. Tailor-made legumain/pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug delivery and in situ monitoring of drug release.
Li Y; Niu Y; Zhu J; Gao C; Xu Q; He Z; Chen D; Xu M; Liu Y
Nanoscale; 2020 Jan; 12(4):2673-2685. PubMed ID: 31942900
[TBL] [Abstract][Full Text] [Related]
10. Photo- and pH-Responsive Polycarbonate Block Copolymer Prodrug Nanomicelles for Controlled Release of Doxorubicin.
Kalva N; Uthaman S; Augustine R; Jeon SH; Huh KM; Park IK; Kim I
Macromol Biosci; 2020 Aug; 20(8):e2000118. PubMed ID: 32567108
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy.
Zhang Y; Xiao C; Li M; Chen J; Ding J; He C; Zhuang X; Chen X
Macromol Biosci; 2013 May; 13(5):584-94. PubMed ID: 23420692
[TBL] [Abstract][Full Text] [Related]
12. Regulation of drug release performance using mixed doxorubicin-doxorubicin dimer nanoparticles as a pH-triggered drug self-delivery system.
Li J; Li X; Xie P; Liu P
J Pharm Anal; 2022 Feb; 12(1):122-128. PubMed ID: 35573875
[TBL] [Abstract][Full Text] [Related]
13. Hydrazone linked doxorubicin-PLA prodrug nanoparticles with high drug loading.
Gatti S; Agostini A; Palmiero UC; Colombo C; Peviani M; Biffi A; Moscatelli D
Nanotechnology; 2018 Jul; 29(30):305602. PubMed ID: 29701613
[TBL] [Abstract][Full Text] [Related]
14. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery.
Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J
ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122
[TBL] [Abstract][Full Text] [Related]
15. The effect of linkers on the self-assembling and anti-tumor efficacy of disulfide-linked doxorubicin drug-drug conjugate nanoparticles.
Wang Y; Wang X; Deng F; Zheng N; Liang Y; Zhang H; He B; Dai W; Wang X; Zhang Q
J Control Release; 2018 Jun; 279():136-146. PubMed ID: 29655991
[TBL] [Abstract][Full Text] [Related]
16. Disulfide/α-Amide-Bridged Doxorubicin Dimeric Prodrug: Effect of Aggregation Structures on pH/GSH Dual-Triggered Drug Release.
Yang C; Liu P
Langmuir; 2024 May; 40(21):11098-11105. PubMed ID: 38739904
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
[TBL] [Abstract][Full Text] [Related]
18. Design of pH/reduction dual-responsive nanoparticles as drug delivery system for DOX: Modulating controlled release behavior with bimodal drug-loading.
Liu P; Zhang R; Pei M
Colloids Surf B Biointerfaces; 2017 Dec; 160():455-461. PubMed ID: 28985607
[TBL] [Abstract][Full Text] [Related]
19. A pH-responsive prodrug delivery system self-assembled from acid-labile doxorubicin-conjugated amphiphilic pH-sensitive block copolymers.
Huang X; Liao W; Xie Z; Chen D; Zhang CY
Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():27-37. PubMed ID: 29853091
[TBL] [Abstract][Full Text] [Related]
20. Acid-responsive PEGylated doxorubicin prodrug nanoparticles for neuropilin-1 receptor-mediated targeted drug delivery.
Song H; Zhang J; Wang W; Huang P; Zhang Y; Liu J; Li C; Kong D
Colloids Surf B Biointerfaces; 2015 Dec; 136():365-74. PubMed ID: 26433349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]